Merck & Co. Is Dangerously Close To A Breakdown
Merck (MRK) is testing a solid support zone this week and so far there has been little interest. At Thursday's low, the stock had extended its March pullback to 5.25% and had worked off its overbought reading. This healthy pullback could soon develop into a deep selloff if the $63.00 area is taken out.